A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Overview of attention for article published in Frontiers in Physiology, September 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 6 X users, with an upper bound of 16,637 followers.

Frontiers | A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial https://t.co/ISzmEuxt51

18 May 2023

Reply Repost Favourite

💉Una sola dosis de 60.000 UI de EPO no mejora el rendimiento aeróbico a corto plazo en sujetos sanos🤔 https://t.co/Qtk9hVvtMU https://t.co/ffZ4oB2LlQ

20 Nov 2020

Reply Repost Favourite

RT @FrontPhysiol: New Research: A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healt…

02 Nov 2020

Reply Repost Favourite

New Research: A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial https://t.co/ehsmCNGAQD #Physiology

02 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.